Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System

被引:311
作者
Montgomery, Sara L. [2 ]
Bowers, William J. [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Neurol, Ctr Neural Dev & Dis, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
关键词
Neuroinflammation; Cytokine; Development; Alzheimer's disease; Parkinson's disease; Multiple Sclerosis; Intracellular signaling; NF-KAPPA-B; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; IMMUNOLOGICAL CROSS-REACTIVITY; ACTIVATED PROTEIN-KINASE; FACTOR RECEPTOR-II; TNF-ALPHA; ALZHEIMERS-DISEASE; CELL-DEATH; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS;
D O I
10.1007/s11481-011-9287-2
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Tumor Necrosis Factor-alpha (TNF-alpha) is a prototypic pro-inflammatory cytokine involved in the innate immune response. TNF-alpha ligation and downstream signaling with one of its cognate receptors, TNF-RI or TNF-RII, modulates fundamental processes in the brain including synapse formation and regulation, neurogenesis, regeneration, and general maintenance of the central nervous system (CNS). During states of chronic neuroinflammation, extensive experimental evidence implicates TNF-alpha as a key mediator in disease progression, gliosis, demyelination, inflammation, blood-brain-barrier deterioration, and cell death. This review explores the complex roles of TNF-alpha in the CNS under normal physiologic conditions and during neurodegeneration. We focus our discussion on Multiple Sclerosis, Parkinson's disease, and Alzheimer's disease, relaying the outcomes of preclinical and clinical testing of TNF-alpha directed therapeutic strategies, and arguing that despite the wealth of functions attributed to this central cytokine, surprisingly little is known about the cell type- and stage-specific roles of TNF-alpha in these debilitating disorders.
引用
收藏
页码:42 / 59
页数:18
相关论文
共 208 条
[1]
Aggarwal B B., 2000, Cytokine Reference Edited by: Oppenheim JJaFM, P1620
[2]
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial [J].
Aisen, PS ;
Schafer, KA ;
Grundman, M ;
Pfeiffer, E ;
Sano, M ;
Davis, KL ;
Farlow, MR ;
Jin, S ;
Thomas, RG ;
Thal, LJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2819-2826
[3]
A randomized controlled trial of prednisone in Alzheimer's disease [J].
Aisen, PS ;
Davis, KL ;
Berg, JD ;
Schafer, K ;
Campbell, K ;
Thomas, RG ;
Weiner, MF ;
Farlow, MR ;
Sano, M ;
Grundman, M ;
Thal, LJ .
NEUROLOGY, 2000, 54 (03) :588-593
[4]
Randomized pilot study of nimesulide treatment in Alzheimer's disease [J].
Aisen, PS ;
Schmeidler, J ;
Pasinetti, GM .
NEUROLOGY, 2002, 58 (07) :1050-1054
[5]
[Anonymous], 1999, Neurology, V53, P457
[6]
TNFα promotes proliferation of oligodendrocyte progenitors and remyelination [J].
Arnett, HA ;
Mason, J ;
Marino, M ;
Suzuki, K ;
Matsushima, GK ;
Ting, JPY .
NATURE NEUROSCIENCE, 2001, 4 (11) :1116-1122
[7]
CONTROL OF ESTABLISHED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY INHIBITION OF TUMOR-NECROSIS-FACTOR (TNF) ACTIVITY WITHIN THE CENTRAL-NERVOUS-SYSTEM USING MONOCLONAL-ANTIBODIES AND TNF RECEPTOR IMMUNOGLOBULIN FUSION PROTEINS [J].
BAKER, D ;
BUTLER, D ;
SCALLON, BJ ;
ONEILL, JK ;
TURK, JL ;
FELDMANN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) :2040-2048
[8]
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease [J].
Banati, RB ;
Daniel, SE ;
Blunt, SB .
MOVEMENT DISORDERS, 1998, 13 (02) :221-227
[9]
CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION [J].
BANNER, DW ;
DARCY, A ;
JANES, W ;
GENTZ, R ;
SCHOENFELD, HJ ;
BROGER, C ;
LOETSCHER, H ;
LESSLAUER, W .
CELL, 1993, 73 (03) :431-445
[10]
TUMOR-NECROSIS-FACTOR-ALPHA AND TUMOR-NECROSIS-FACTOR-BETA PROTECT NEURONS AGAINST AMYLOID BETA-PEPTIDE TOXICITY - EVIDENCE FOR INVOLVEMENT OF A KAPPA-B-BINDING FACTOR AND ATTENUATION OF PEROXIDE AND CA2+ ACCUMULATION [J].
BARGER, SW ;
HORSTER, D ;
FURUKAWA, K ;
GOODMAN, Y ;
KRIEGLSTEIN, J ;
MATTSON, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9328-9332